The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy ...

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a ...

Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side ...

The world of prior authorization, and the hoops we need to jump through, has gotten just more and more ridiculous, bordering ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

In today's Morning Rounds newsletter: a failed long Covid drug may get another shot, the benefits of even a little activity ...

West Pharmaceutical Services Inc. (NYSE: WST) is one of the most oversold S&P 500 stocks so far in 2025. On June 24, Barclays ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

People taking weight-loss drugs… including popular GLP-1s … may regain a significant amount of weight within months of ...

Explore how semaglutide and tirzepatide may protect against dementia and stroke—keep reading for clinical implications and evidence.

Frequent alcohol consumption is linked to more than 20 health conditions, including stroke, hypertension and cardiovascular disease. The effects are often delayed by two years or more, which can make ...

For patients with type 2 diabetes, GLP-1 RAs are associated with an increased risk for GERD compared with SGLT-2 inhibitors.